Skip to content
Billionaire Profile
Leopoldo Espinosa Abdalá
Global Rank
#2561

Leopoldo Espinosa Abdalá

CEO, Pharmaceutical
Zapopan, Mexico
Real-Time Net Worth
$1.58B
Estimated based on Pharmaceutical stock value as of September 10, 2026
0% (24h)
Age
Source
Pharmaceutical
Industry
Healthcare
Citizenship
Mexico

Biography

Leopoldo Espinosa Abdalá is a Mexican billionaire, primarily known for his wealth derived from the pharmaceutical industry. He gained prominence as a result of the 2016 sale of Rimsa, a Mexican pharmaceutical company, to Teva Pharmaceutical Industries for $2.3 billion. This transaction significantly boosted his net worth. Espinosa Abdalá and his brother have maintained a low public profile, focusing on strategic investments. Their business acumen and ability to navigate the complexities of the healthcare sector have been key to their success and have solidified their position among Mexico's wealthiest individuals.

AI-Assisted Draft
Not yet reviewed by an editor — how we work
Data Updated
Sep 10, 2026
Report a Correction

Wealth Over Time

Net Worth History

YearNet Worth
2026$1.58B
2025$1.60B
2024$1.60B
2023$2.30B
2021$2.45B
2020$2.45B

Portfolio Holdings

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries

TEVAPharmaceuticals
Tel Aviv, Israel
43,000 employees
Founded 1901

In-Depth Profile

Early Life

Details about Leopoldo Espinosa Abdalá's early life are scarce, as he and his brother have maintained a low profile. The business was founded by their father in 1970 as a pharmaceutical distributor before expanding into manufacturing.

Rise to Success

Leopoldo Espinosa Abdalá, along with his brother Fernando, built their wealth through the pharmaceutical company Rimsa. The company was a major supplier of pharmaceutical products in Mexico. The pivotal moment in their career was the 2016 sale of Rimsa to Teva Pharmaceutical Industries for $2.3 billion.

Key Business Strategies

The primary business strategy of Leopoldo Espinosa Abdalá has been building and growing Rimsa. After the sale of Rimsa, the Espinosa Abdalá brothers have focused on managing their existing wealth and investments. They have been known to maintain a low profile, avoiding media attention and public appearances. The sale of Rimsa to Teva and subsequent management of their wealth has been the core of their business strategy.

Philanthropy

Information about Leopoldo Espinosa Abdalá's philanthropic activities is not readily available. Public records do not show any major, publicized philanthropic initiatives.

Career Milestones

1970

Pharmaceutical Distributor

Father founded the business as a pharmaceutical distributor.

2016

Sale of Rimsa

Sold Rimsa to Teva Pharmaceutical Industries for $2.3 billion.

Philanthropy & Social Impact

Information not available

Information not available

$XB

Information not available

Business Philosophy & Leadership

Notable Quotes

"Information not available"

Leadership Principles

Information not available

Information not available

Controversies & Challenges

2016

Teva Lawsuit

Teva sued Leopoldo and his brother Fernando, alleging fraud and breach of contract related to the sale of Rimsa. The charges were mostly dismissed, and the parties settled for less than $200 million.

Billionaires Connected to Leopoldo Espinosa Abdalá

Frequently Asked Questions

What is Leopoldo Espinosa Abdalá's net worth in 2026?
As of 2026, Leopoldo Espinosa Abdalá's estimated net worth is $1.575 billion, ranking #2561 among the world's billionaires. The estimate is based on publicly available shareholding data and market prices, updated daily.
How did Leopoldo Espinosa Abdalá make their money?
Leopoldo Espinosa Abdalá's wealth primarily comes from Pharmaceutical, most notably through Pharmaceutical.
Where is Leopoldo Espinosa Abdalá from?
Leopoldo Espinosa Abdalá is from Mexico.

Sources & References

Citations for this profile have not been published yet. Net worth figures here are estimates and should not be treated as verified. See our methodology for how these estimates are produced, or report a correction.